Bruker Corporation (NASDAQ:BRKR) Cowen 43rd Annual Health Care Conference March 6, 2023 2:10 PM ET Company Participants Gerald Herman - EVP & CFO Conference Call Participants Max Masucci - Cowen & Co. Max Masucci Well again, welcome to TD Cowen's 43rd Annual Health Care Conference. I'm Max Masucci, one of the Life Science and Diagnostic Tools analysts here. We are pleased to be joined today by Bruker, one of the three large cap names in our coverage. And a diversified participant in several of the tools, di ...

Bruker Corporation (NASDAQ:BRKR) 2023 Citi Healthcare Services, Medtech, Tools & HCIT Conference March 2, 2023 9:30 AM ET Company Participants Gerald Herman - EVP & CFO Conference Call Participants Patrick Donnelly - Citi Patrick Donnelly All right. We can look to get started. Thanks, everyone for being here. I'm Patrick Donnelly, the Tools and Diagnostics analyst here at Citi. Happy to have Gerald Herman, CFO of Bruker with us for this session. Gerald Herman Hello. Patrick Donnelly Gerald, thanks for bei ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to __________ Commission File Number 000-30833 Delaware 04-3110160 (State or other jurisdiction of Incorporation or organization) (I.R.S. Employer Identification No.) 40 Mann ...

Bruker Corporation (NASDAQ:BRKR) Q4 2022 Earnings Conference Call February 9, 2023 8:30 AM ET Company Participants Justin Ward - Senior Director of Investor Relations & Corporate Development Frank Laukien - Chairman, President and Chief Executive Officer Gerald Herman - Executive Vice President and Chief Financial Officer Conference Call Participants Puneet Souda - SVB Securities Patrick Donnelly - Citi Jack Meehan - Nephron Josh Waldman - Cleveland Research Rachel Vatnsdal - JPMorgan Derik Bruin - Bank of ...

Bruker Corporation (NASDAQ:BRKR) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Justin Ward - Senior Director of Investor Relations & Corporate Development Frank Laukien - Chairman, President & Chief Executive Officer Gerald Herman - Executive Vice President & Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Patrick Donnelly - Citi Puneet Souda - SVB Securities Dan Arias - Stifel Josh Waldman - Cleveland Research Nisarg Shah - Bank of America Rach ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the transition period from to Commission File Number 000-30833 BRUKER CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-3110160 (State or other jurisdiction of incorp ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the transition period from to Commission File Number 000-30833 BRUKER CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-3110160 (State or other jurisdiction of incorporati ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the transition period from to Commission File Number 000-30833 BRUKER CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-3110160 (State or other jurisdiction of incorporat ...

Bruker Corporation (NASDAQ:BRKR) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Justin Ward - Senior Director of Investor Relations and Corporate Development Frank Laukien - Chairman, President and Chief Executive Officer Gerald Herman - Executive Vice President and Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink LLC Brandon Couillard - Jefferies & Co. Joshua Waldman - Cleveland Research Patrick Donnelly - Citigroup Inc. Jack Meehan - Nephron Res ...

Bruker Corporation (NASDAQ:BRKR) Cowen's 42nd Annual Health Care Conference March 7, 2022 2:50 PM ET Company Participants Gerald Herman - EVP, CFO Conference Call Participants Max Masucci - Cowen Max Masucci Hi. Good afternoon. Welcome to Cowen's 42nd Annual Health Care Conference. I'm Max Masucci from Cowen's Life Science and Diagnostic Tools Research Team. We're pleased to be joined today by Bruker, which is one of the 3 large cap names in our coverage and a diversified participant in several life science ...